How Mass Spectrometry Reads a Peptide One Fragment at a Time

How Mass Spectrometry Reads a Peptide One Fragment at a Time

A mass number alone cannot tell you the order of a peptide's amino acids. A lab confirms sequence by breaking the molecule apart and rebuilding it from the pieces.

The idea sounds nearly impossible at first.

You hold a peptide, a short chain of amino acids, and you want to know their exact order. A scale can tell you how much the whole chain weighs. But a scale cannot tell you whether a chain of three beads runs A-B-C or C-B-A. Both weigh the same.

A mass spectrometer does read order, though. It does it the way you would rebuild a sentence that was cut into words: by looking at the pieces, not the whole.

A mass is a starting point, not an answer

The first thing a mass spectrometer measures is the mass of the intact peptide. That number is useful. It rules out countless wrong sequences on the spot.

But a mass is not unique. Two peptides built from the same amino acids in a different order carry identical molecular weights. Order matters, and a single number carries none of it.

So the instrument does something more aggressive. It breaks the molecule on purpose.

Breaking the chain at the weak points

This two-stage process, isolating a single ion and then fragmenting it, is called tandem mass spectrometry, or MS/MS.

When the selected peptide receives a push of energy, often by colliding with gas molecules inside the instrument, it fragments. Not at random. Peptides tend to break along the bonds of the backbone, the repeating spine that holds the amino acids together.

The result is a set of smaller pieces, each still carrying part of the original chain.

And here is the key. Every piece reveals how many amino acids it holds from one end.

An alphabet for the pieces

In 1984, the researchers Peter Roepstorff and Jan Fohlman proposed a shared vocabulary for these fragments, and the field still uses it. Fragments that keep the amino end, the N-terminus, are labeled a, b, and c. Fragments that keep the acid end, the C-terminus, are labeled x, y, and z.

The naming later grew more elaborate, and the review "The ABC's (and XYZ's) of peptide sequencing" by Hanno Steen and Matthias Mann remains a standard guide to how the alphabet works.

The labels simply count. A b2 ion holds two amino acids from the N-terminal end. A y3 ion holds three from the C-terminal end.

Reading the gaps between sizes

Now comes the trick that makes sequencing work.

Line up the fragments from one end, in order, and look at the gaps between their masses. The difference between a b2 ion and a b3 ion is exactly the mass of the third amino acid.

Read the gaps one at a time and you have read the sequence left to right. Do the same with the y series and you read it right to left. The two ladders should agree, each one cross-checking the other.

This is the arithmetic at the center of peptide identification. The instrument does not see a sequence. It measures a series of sizes, and the sequence lives in the spaces between them.

From spectrum to sequence

Raw fragments do not spell out a sentence to the person reading them. The instrument compares them against computed predictions, using two broad strategies.

In a database search, software works out which fragments each candidate sequence should produce, then scores how well the observed fragments match. This is the standard path for identifying peptides from a known protein, which is first digested into smaller peptides. Stanford University Mass Spectrometry, in Palo Alto, describes this workflow, running nanoLC-MS/MS with several fragmentation modes and database search tools such as Sequest and Byonic.

In de novo sequencing, software builds the sequence from the fragments themselves, with no candidate list to lean on. It is slower and harder, but it is the only option when the answer is genuinely unknown.

What this means when you read a test report

All of this matters when a certificate or report states that a peptide's sequence was "confirmed by MS."

Confirmation is not a single yes-or-no stamp. It depends on how much of the sequence the fragments covered, whether enough ions were detected to anchor the order, and how well the observed spectrum matched the predicted one. A weak match, or coverage across only part of the chain, is a weaker claim.

If you want to know how confident a sequence assignment really is, ask for the fragmentation data behind it, not just the one-line conclusion.

The whole is rebuilt from the parts

A mass spectrometer does not look at a peptide and simply read it off. It smashes the molecule, weighs the pieces, and reconstructs the order from the gaps between them. Sequence is inferred carefully, not pulled whole from a single number.

Understanding how sequence gets confirmed is part of reading test documentation well. If you are evaluating a research compound, ask what the report actually shows, not just what its headline says.

For research use only. Not for human or veterinary consumption.

Sources

• Roepstorff, P., and J. Fohlman. "Proposal for a Common Nomenclature for Sequence Ions in Mass Spectra of Peptides." Biomedical Mass Spectrometry 11, no. 11 (1984): 601. doi:10.1002/bms.1200111109. https://pubmed.ncbi.nlm.nih.gov/6525415/

• Steen, Hanno, and Matthias Mann. "The ABC's (and XYZ's) of Peptide Sequencing." Nature Reviews Molecular Cell Biology 5, no. 9 (2004): 699-711. doi:10.1038/nrm1468. https://pubmed.ncbi.nlm.nih.gov/15340378/

• Stanford University Mass Spectrometry. "Protein Identification." Accessed October 2026. https://mass-spec.stanford.edu/protein-identification

• Matrix Science (Mascot). "Peptide Fragmentation: Sequence Ions." Accessed October 2026. https://mascot.biotech.illinois.edu/mascot/help/fragmentation_help.html